Skip to content

Author

Mahyar Etminan

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Ocular Surface Disease as an Immune-related Adverse Event of Immune Checkpoint Inhibitor Therapy.

PURPOSE Ocular surface disease, encompassing scleritis, episcleritis, keratitis, and sicca syndrome, is an increasingly recognized immune-related adverse event of immune checkpoint inhibitors (ICIs), yet its pharmacovigilance profile has not been systematically characterized across all approved ICI classes. We conducte...

C. Frey, Mahyar Etminan, S. Yeung · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.